微创肝切除术后肝衰竭的术前预测因素
本研究为多中心前瞻性队列研究,纳入意大利微创肝手术注册中心的490例连续患者,旨在识别肝硬化及慢性肝病患者微创肝切除术后肝衰竭(PHLF)的预测因素并建立风险预测模型。结果显示PHLF发生率为18.2%,独立预测因素为ALBI评分和腹水,基于CART模型可将患者分为低、中、高风险三组,三组PHLF发生率分别为10.6%、21.3%和63.2%。
要点
- ALBI评分和腹水是微创肝切除术后PHLF的独立预测因素。
- 基于ALBI和腹水的CART模型可将PHLF风险分为低、中、高三组。
- 高风险组(ALBI 2/3级且腹水)PHLF发生率高达63.2%,术后并发症和住院时间也相应增加。
核心结论
- 通过术前易获取的ALBI评分和腹水情况可对微创肝切除术后PHLF风险进行分层,为临床决策提供客观工具。
研究设计与样本
- 多中心前瞻性队列研究,纳入意大利微创肝手术注册中心(I go MILS)490例连续接受微创肝切除的患者,并回顾性补充生化及临床数据。
主要发现
- 490例患者中女性占26.5%,PHLF发生于89例(18.2%)。
- PHLF的独立预测因素为ALBI评分(OR 3.213;95% CI 1.661-6.215;p<0.0001)和腹水(OR 3.320;95% CI 1.468-7.508;p=0.004)。
- CART模型划分三组:ALBI 1级低风险组PHLF 23/217(10.6%),ALBI 2或3级无腹水中风险组54/254(21.3%),ALBI 2或3级伴腹水高风险组12/19(63.2%),p<0.0001。
- 三组术后并发症发生率分别为20.0%、27.5%和66.7%,综合并发症指数分别为5.1±11.1、6.0±10.9和18.8±18.9,住院时间分别为6.0±4.0、6.0±6.0和8.0±5.0天。
临床怎么用
- 术前应常规评估ALBI评分和腹水情况,以识别PHLF高风险患者并优化手术决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Post-hepatectomy liver failure (PHLF) represents the most frequent complication after liver surgery, and the most common cause of morbidity and mortality. Aim of the study is to identify the predictors of PHLF after mini-invasive liver surgery in cirrhosis and chronic liver disease, and to develop a model for risk prediction. METHODS: The present study is a multicentric prospective cohort study on 490 consecutive patients who underwent mini-invasive liver resection from the Italian Registry of Mini-invasive Liver Surgery (I go MILS). Retrospective additional biochemical and clinical data were collected. RESULTS: On 490 patients (26.5% females), PHLF occurred in 89 patients (18.2%). The only independent predictors of PHLF were Albumin-Bilirubin (ALBI) score (OR 3.213; 95% CI 1.661-6.215; p < .0.0001) and presence of ascites (OR 3.320; 95% CI 1.468-7.508; p = 0.004). Classification and regression tree (CART) modeling led to the identification of three risk groups: PHLF occurred in 23/217 patients with ALBI grade 1 (10.6%, low risk group), in 54/254 patients with ALBI score 2 or 3 and absence of ascites (21.3%, intermediate risk group) and in 12/19 patients with ALBI score 2 or 3 and evidence of ascites (63.2%, high risk group), p < 0.0001. The three groups showed a corresponding increase in postoperative complications (20.0%, 27.5% and 66.7%), Comprehensive Complication Index (5.1 ± 11.1, 6.0 ± 10.9 and 18.8 ± 18.9) and hospital stay (6.0 ± 4.0, 6.0 ± 6.0 and 8.0 ± 5.0 days). CONCLUSION: The risk of PHLF can be stratified by determining two easily available preoperative factors: ALBI and ascites. This model of risk prediction offers an objective instrument for a correct clinical decision-making.
引用
- Sposito C, Monteleone M, Aldrighetti L, et al. Preoperative predictors of liver decompensation after mini-invasive liver resection. Surg Endosc. 2020. PMID: 32124061. doi:10.1007/s00464-020-07438-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。